Critical care management of chimeric antigen receptor T-cell therapy recipients
Critical care management of chimeric antigen receptor T-cell therapy recipients
About this item
Full title
Author / Creator
Publisher
Atlanta: Wiley Subscription Services, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: Wiley Subscription Services, Inc
Subjects
More information
Scope and Contents
Contents
Chimeric antigen receptor (CAR) T-cell therapy is a promising immunotherapeutic treatment concept that is changing the treatment approach to hematologic malignancies. The development of CAR T-cell therapy represents a prime example for the successful bench-to-bedside translation of advances in immunology and cellular therapy into clinical practice....
Alternative Titles
Full title
Critical care management of chimeric antigen receptor T-cell therapy recipients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2625331779
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2625331779
Other Identifiers
ISSN
0007-9235
E-ISSN
1542-4863
DOI
10.3322/caac.21702
